InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Kennedy Patrick. Director active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 4 disclosures have been logged. History available since 1 March 2024. The latest transaction was filed on 5 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Kennedy Patrick is a declarant with 4 filings in total. The 4 sampled filings concern Jazz Pharmaceuticals plc, where he is listed as Director, and cover the period from 2024-03-05 to 2026-08-07. The reported buy volume and sell volume for these recent filings are 0 each, and the most frequent transaction nature is Attribution.